[HTML][HTML] Application of green gold nanoparticles in cancer therapy and diagnosis

S Sargazi, U Laraib, S Er, A Rahdar, M Hassanisaadi… - Nanomaterials, 2022 - mdpi.com
Nanoparticles are currently used for cancer theranostics in the clinical field. Among
nanoparticles, gold nanoparticles (AuNPs) attract much attention due to their usability and …

Mature and immature ovarian teratomas: CT, US and MR imaging characteristics

L Saba, S Guerriero, R Sulcis, B Virgilio… - European journal of …, 2009 - Elsevier
Ovarian teratomas (OTs) are the most common germ cell neoplasm. They include mature
cystic teratomas, monodermal teratomas (neural tumors, struma ovarii, carcinoid tumors) …

[PDF][PDF] Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with …

BE Hillner, BA Siegel, D Liu, AF Shields… - Journal of Clinical …, 2008 - Citeseer
Purpose Under Medicare's Coverage with Evidence Development policy, positron emission
tomography (PET)/computed tomography (CT) and PET became covered services for …

18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis

EE Pakos, AD Fotopoulos… - Journal of Nuclear …, 2005 - Soc Nuclear Med
The ability of PET with 18F-FDG to evaluate bone marrow infiltration in patients with
lymphoma has been a matter of extensive investigation with controversial results. Therefore …

Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection

E Even-Sapir, Y Parag, H Lerman, M Gutman, C Levine… - Radiology, 2004 - pubs.rsna.org
PURPOSE: To assess diagnostic accuracy of combined positron emission tomography
(PET) and computed tomography (CT) in detection of pelvic recurrence in patients with rectal …

[HTML][HTML] Molecular imaging for personalized cancer care

MF Kircher, H Hricak, SM Larson - Molecular oncology, 2012 - Elsevier
Molecular imaging is rapidly gaining recognition as a tool with the capacity to improve every
facet of cancer care. Molecular imaging in oncology can be defined as in vivo …

Detection of clinically unexpected malignant and premalignant tumors with whole-body FDG PET: histopathologic comparison

H Agress Jr, BZ Cooper - Radiology, 2004 - pubs.rsna.org
PURPOSE: To determine the clinical importance and malignant potential of unexpected
abnormal foci of hypermetabolism at fluorodeoxyglucose (FDG) positron emission …

Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis

YY Lu, JH Chen, CR Chien, WTL Chen, SC Tsai… - International journal of …, 2013 - Springer
Aim The purpose of the present study was to conduct a systematic review and meta-analysis
of the published literature to assess the diagnostic performance of FDG-PET or PET/CT in …

Positron emission tomography in oncology: a review

KA Wood, PJ Hoskin, MI Saunders - Clinical Oncology, 2007 - Elsevier
Positron emission tomography is an evolving imaging tool that is becoming increasingly
available for use in clinical practice. This overview will look at the current evidence for the …

Early Detection of Tumor Response to Chemotherapy by 3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography: The Effect of Cisplatin on a Fibrosarcoma Tumor …

J Leyton, JR Latigo, M Perumal, H Dhaliwal, Q He… - Cancer research, 2005 - AACR
We have assessed the potential of [18F] fluorothymidine positron emission tomography
([18F] FLT-PET) to measure early cytostasis and cytotoxicity induced by cisplatin treatment of …